Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications

Oncogene

Volumn 25, Issue 53, 2006, Pages 7041-7058

  Balkhi, M Y ^a   Trivedi, A K ^a   Geletu, M ^a   Christopeit, M ^a   Bohlander, S K ^b   Behre, H M ^a   Behre, G ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute myeloid leukaemia; Mass spectrometry; Post translational modification; Proteomics

Indexed keywords

APOPTOSIS INHIBITOR; BETA O N ACETYLGLUCOSAMINE; CALRETICULIN; CASEIN KINASE IALPHA; GLUCOSAMINE DERIVATIVE; HEAT SHOCK COGNATE PROTEIN 70; MYC PROTEIN; PROHIBITIN; PROTEIN; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE 1; SURVIVIN; UNCLASSIFIED DRUG;

ACETYLATION; ACUTE GRANULOCYTIC LEUKEMIA; AMINO ACID SEQUENCE; ARTICLE; CHROMOSOME 11Q; CHROMOSOME 21; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KARYOTYPE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHYLATION; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CELL SHAPE; CYTOGENETICS; FEMALE; GENE REGULATORY NETWORKS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MASS SPECTROMETRY; METHYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; PROTEOMICS; RISK FACTORS;

EID: 33750873600     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209689     Document Type: Article

References (29)

1. Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M et al. (2005). Clin Cancer Res 11: 1416-1424.
2. Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R et al. (2004). N Engl J Med 350: 1605-1616.
3. Cristea IM, Gaskell SJ, Whetton AD. (2004). Blood 103: 3624-3634.
4. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. (1998). Blood 92: 2322-2333.
5. Gurbuxani S, Xu Y, Keerthivasan G, Wickrema A, Crispino JD. (2005). Proc Natl Acad Sci USA 102: 11480-11485.
6. Haferlach T, Schnittger S, Kern W, Hiddemann W, Schoch C. (2004). Ann Hematol 83(Suppl 1): S97-S100.
7. Helbling D, Mueller BU, Timchenko NA, Hagemeijer A, Jotterand M, Meyer-Monard S et al. (2004). Proc Natl Acad Sci USA 101: 13312-13317.
8. Helbling D, Mueller BU, Timchenko NA, Schardt J, Eyer M, Betts DR et al. (2005). Blood 106: 1369-1375.
9. Herman JG, Baylin SB. (2003). N Engl J Med 349: 2042-2054.
10. Igarashi K, Itoh K, Hayashi N, Nishizawa M, Yamamoto M. (1995). Proc Natl Acad Sci USA 92: 7445-7449.
11. Khidekel N, Ficarro SB, Peters EC, Hsieh-Wilson LC. (2004). Proc Natl Acad Sci USA 101: 13132-13137.
12. Li C, Ai LS, Lin CH, Hsieh M, Li YC, Li SY. (1998a). Arch Biochem Biophys 351: 53-59.
13. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC et al. (1998b). Nature 396: 580-584.
14. Lin CH, Hsieh M, Li YC, Li SY, Pearson DL, Pollard KM et al. (2000). J Biochem (Tokyo) 128: 493-498.
15. Lominadze G, Rane MJ, Merchant M, Cai J, Ward RA, McLeish KR. (2005). J Immunol 174: 7257-7267.
16. Mann M, Jensen ON. (2003). Nat Biotechnol 21: 255-261.
17. Marcucci G, Mrozek K, Ruppert AS, Archer KJ, Pettenati MJ, Heerema NA et al. (2004). J Clin Oncol 22: 2410-2418.
18. Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW. (2005). Proc Natl Acad Sci USA 102: 10852-10857.
19. Petricoin III EF, Bichsel VE, Calvert VS, Espina V, Winters M, Young L et al. (2005). J Clin Oncol 23: 3614-3621.
20. Sagi D, Kienz P, Denecke J, Marquardt T, Peter-Katalinic J. (2005). Proteomics 5: 2689-2701.
21. Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL et al. (2001). Blood 98: 3413-3420.
22. Schoch C, Kern W, Kohlmann A, Hiddemann W, Schnittger S, Haferlach T. (2005). Genes Chromosomes Cancer 43: 227-238.
23. Timchenko LT, Iakova P, Welm AL, Cai ZJ, Timchenko NA. (2002). Mol Cell Biol 22: 7242-7257.
24. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ. (1996). Genes Dev 10: 804-815.
25. Vosseller K, Wells L, Hart GW. (2001). Biochimie 83: 575-581.
26. Wang Z, Rolish ME, Yeo G, Tung V, Mawson M, Burge CB. (2004). Cell 119: 831-845.
27. Wells L, Whelan SA, Hart GW. (2003). Biochem Biophys Res Commun 302: 435-441.
28. Wolffe AP, Matzke MA. (1999). Science 286: 481-486.
29. Zhou J, Nong L, Wloch M, Cantor A, Mulshine JL, Tockman MS. (2001). Lung Cancer 34: 341-350.